Remind Me

Privacy

CSL Biotherapies (NZ) Ltd ("CSL, we or us") understands the importance of safeguarding the privacy of information that we collect from our on-line visitors via the Internet. Because the Internet offers the ability to collect certain types of information, we have set out below the terms and conditions surrounding the capture and use of the information we gather.


Should we change this privacy policy for any reason, such changes will always be posted on this webpage. However, if you have any further questions relating to this privacy policy, please do not hesitate
to email us at nzadmin@csl.co.nz.

Capture of Information:
Through the websites which CSL operate, we may collect two types of information about you:

1. Personal information which is provided voluntarily by you upon registration for the services that we offer. Normally, this information includes your first and last names, title, email address, location address and office telephone number. You may view and have this information modified by contacting us at nzadmin@csl.co.nz. From time to time, CSL may collect additional personal information from users of the website in connection with optional surveys, news updates or promotions that you are asked to participate in through the website. Providing this information is optional. Feedback from surveys will be used to improve the website.

2. Compiled information generated by our systems or third party systems we use, which track traffic, but which does not relate to you personally.

We only use your personal information to:
Help us to provide our products and services;

Improve our service;

Inform or keep you updated on products or services you have indicated an interest in;

Inform or update you about additional services.

Disclosure of Information:
CSL may disclose your personal information to third parties:

When required to do so by law; or

After seeking your prior permission before doing this. Permission is usually obtained at the time of collecting the information from you.

We will not use your personal information without taking such steps as are reasonable in the circumstances to ensure that the information is accurate, up-to-date and not misleading.

Personal information collected by CSL may be transferred to other websites of CSL where it is necessary for the purposes for which you submitted the information. By submitting personal information on CSL's website, you consent to transborder transmission of information provided that such information remains in the control of CSL.

Cookies and Tracking:
We may, via the website, set and access "cookies" on your computer to provide assurance that our proprietary content and third party content is only accessed by users with appropriate authorisation to the website. Many browsers recognise when a cookie is offered, and allow you to decide whether to accept it. The cookie file is completely anonymous and provides no personal information about website users. CSL often uses the information generated by cookies to:

Measure or monitor patterns of usage to and from our websites. For example, the pages you visited, the time you spend on each page, the date you visited and referring pages;

Ensure any advertising displayed on our site is reaching its correct audience; and

Ensure that you are able to enter our websites without having to log-on every time.

Security Procedures:
To prevent unauthorised access, to maintain data accuracy and to ensure appropriate use of any personal information supplied by you, we have put in place physical, electronic and managerial processes to protect the information you provide on the website. Additionally, all stored user information is protected from unauthorised access through the use of secure passwords, user log-ons and other security procedures.

Permission-based communication:
If any collection, use or disclosure of your personal information is outside the regulations set out in this Privacy Policy, we will provide you with the option to either:

Elect not to receive future similar communication from CSL; or

Elect to continue to receive future similar communication from CSL.

Links to other websites:
The CSL website may contain links to other websites. CSL is not responsible for the privacy policies of such other websites. This privacy policy applies solely to information collected on the website by us.

Duration of storage of personal information:

CSL will only retain your personal information for as long as necessary to fulfil the purposes for which the information was collected or as required by law.

The Privacy Act (1993):
Your personal information is kept on our own computer and is totally secure. You have the right at any time to have access to, and update, correct or remove the information about you that we hold. If you do not wish to receive future information about our products, all you have to do is write to us at CSL Biotherapies (NZ) Ltd, PO Box 62 590, Central Park, Auckland 1544; email us at nzadmin@csl.co.nz; or freephone 0800 502 757.

Immunisation does not replace the need for regular cervical smear testing.

*Girls aged 9 up to those born on or after 1 January 1990 are eligible for free immunisation through a doctor, medical clinic or school based programme. A patient charge applies for all ages outside this range.

GARDASIL™ [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine] GARDASIL is a prescription medicine that is fully funded for females born between 1 January 1990 and 31 December 1999. Please refer to the Ministry of Health for the eligibility criteria for girls younger than 11. A patient charge applies for all others outside this range. Indication: GARDASIL is a vaccine that helps prevent the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16 or 18: cervical cancer (cancer of the lower end of the uterus or womb), vulvar (the outside of the female genitals) and vaginal cancers, abnormal and precancerous cervical lesions (changes in cells of the cervix which have a risk of turning into cancer) as found by a Pap test, genital warts, and HPV infection. GARDASIL helps prevent, but does not treat these diseases. You cannot get these diseases from GARDASIL. GARDASIL can be given to females aged 9 to 45 years and males aged 9 to 15 years. Contraindications: Do not, or do not let your child have GARDASIL if you or your child have had an allergy to any of the ingredients or if you or your child have had an allergic reaction after receiving a dose of the vaccine. If you are not sure whether you or your child should be given GARDASIL, talk to your doctor or health care provider. Warnings and Precautions: Tell your doctor or health care provider if you or your child: has had an allergic reaction to the vaccine, has a bleeding disorder and cannot receive injections in the arm, has any illness with a fever higher than 100°F (37.8°C), is pregnant or is planning to get pregnant, takes or plans to take any medicines, including ones you buy without a prescription from your pharmacy, supermarket, or health food shop, has a weakened immune system, for example due to a genetic defect or Human Immunodeficiency Virus (HIV) infection. Adverse Reactions: Tell your doctor or pharmacist as soon as possible if you or your child do not feel well during or after having had an injection of GARDASIL. Tell your doctor if you or your child have any of the following and they are troublesome or ongoing: pain, itching, tenderness, or soreness at the injection site, local reaction around the injection site such as soreness, redness, or swelling, fever, dizziness, nausea and vomiting, pain in the extremities. Fainting, sometimes accompanied by shaking or stiffening, has been reported. Although fainting episodes are uncommon, patients should be observed for 15 minutes after they receive HPV vaccination. As with other vaccines, side effects that have been reported during general use include: headache, swollen glands in the neck, armpit and groin, joint pain, aching muscles, unusual tiredness or weakness, chills, generally feeling unwell, and allergic reactions. If any of the above symptoms worsen or you or your child has any unusual or severe symptoms after receiving GARDASIL, contact your doctor or health care provider right away. Ingredients: The active ingredients of GARDASIL are highly purified inactive proteins from HPV Types 6, 11, 16 and 18.

For more information, please contact your health care provider or CSL Biotherapies (NZ) Ltd, PO Box 62 590, Central Park, Auckland 1544, Freephone 0800 502 757 or www.cslbiotherapies.co.nz. GARDASIL™ is a registered trademark of Merck & Co. Inc. Whitehouse Station, NJ, 08889 USA. GARD-143-09/09 TAPS CH2448 Date of Preparation: September 2009.

Disclaimer: The information in this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding GARDASIL must be made with a healthcare provider. The product information provided in this site is intended for residents of New Zealand. Audiences outside New Zealand should refer to the product information in their own country, as different regulatory regimes may apply. GARDASIL is distributed in New Zealand by CSL Biotherapies (NZ) Ltd.